VacLogic+ Maintenance Release 1.6.0 | All Practices: September 12, 2024

Forecasting Revisions

Based on FDA / CDC guidelines, this version of VacLogic+ forecasting has been revised to accurately reflect the following recommendations:

PENBRAYA / Meningitis B

• Added new logic to reflect administration of PENBRAYA, the new MenACWY - Men B vaccine to forecast appropriately for both Meningitis ACWY as well as Meningitis B schedules, according to CDC/ACIP guidelines for its use.
• Updated Meningitis B forecasting will account for a new UI design change added in 21.3.64 to reflect the choices of:
• Meningitis B not forecast (default)
• Meningitis B Shared Decision Making (Forecasting will start at age 16)
• Meningitis B high risk (Forecasting starts at age 10)
• PLEASE NOTE: the forecasting specifically for PENBRAYA will require that practices are running OP 21.3.64. Earlier versions will incorrectly display a documented dose of PENBRAYA